|
End-of-day quote
Shenzhen S.E.
2026-10-09
|
5-day change | 1st Jan Change | ||
| 8.570 CNY | +2.27% |
|
-0.92% | -19.00% |
| Market Cap | 4.13B 616M 550M 512M 466M 879M 59.64B 883M 6.16B 2.41B 30.41B 2.31B 2.26B 97.58B | P/E 2024 |
-50.1x | P/E 2025 | 353x |
|---|---|---|---|---|---|
| Enterprise Value | 2.59B 386M 345M 321M 292M 551M 37.36B 553M 3.86B 1.51B 19.05B 1.45B 1.42B 61.13B | EV / Sales 2024 |
4.33x | EV / Sales 2025 | 8.78x |
| Free-Float |
42.39% | Yield 2024 * |
-
| Yield 2025 | 2.84% |
| 1 day | +2.27% | ||
| 1 week | -0.92% | ||
| Current month | -0.92% | ||
| 1 month | +1.30% | ||
| 3 months | -11.92% | ||
| 6 months | -25.15% | ||
| Current year | -19.00% |
| 1 week | 8.15 |  | 8.88 |
| 1 month | 8.06 | | 8.88 |
| Current year | 7.77 | | 12.9 |
| 1 year | 7.77 | | 13.8 |
| 3 years | 5.73 | | 17.49 |
| 5 years | 5.73 | | 18.75 |
| 10 years | 5.73 | | 28.08 |
| Manager | Title | Age | Since |
|---|---|---|---|
Biao Ma
CEO | Chief Executive Officer | 62 | 2001-07-04 |
Dong Na Liang
DFI | Director of Finance/CFO | 45 | 2024-01-25 |
Li Ma
DFI | Director of Finance/CFO | 57 | 2006-12-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Xue Feng Wang
BRD | Director/Board Member | 48 | 2009-02-28 |
Biao Ma
CHM | Chairman | 62 | 2001-07-04 |
Li Ma
BRD | Director/Board Member | 57 | 2005-09-30 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +2.27% | -0.92% | -23.89% | -24.29% | 616M | |
| +0.83% | +3.19% | +41.49% | +103.56% | 1,051B | |
| +1.93% | +2.11% | +37.08% | +65.09% | 630B | |
| +1.49% | +5.19% | +19.94% | +85.69% | 489B | |
| +2.26% | +0.90% | +69.32% | +40.53% | 359B | |
| +1.45% | +3.50% | +23.29% | +41.62% | 344B | |
| +1.17% | +2.37% | +13.47% | +33.64% | 272B | |
| +0.89% | +1.08% | -6.13% | +9.29% | 246B | |
| +1.82% | +2.94% | +42.99% | +52.95% | 224B | |
| +2.77% | +4.44% | +29.01% | +98.99% | 187B | |
| Average | +1.69% | +2.38% | +24.66% | +50.71% | 380.43B | |
| Weighted average by Cap. | +1.47% | +2.44% | +33.35% | +69.00% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 416M 62.18M 55.53M 51.66M 46.99M 88.72M 6.02B 89.1M 622M 244M 3.07B 233M 228M 9.85B | 405M 60.42M 53.96M 50.2M 45.66M 86.21M 5.85B 86.59M 604M 237M 2.98B 227M 222M 9.57B |
| Net income | -68.85M -10.28M -9.18M -8.54M -7.77M -14.67M -995M -14.73M -103M -40.27M -507M -38.6M -37.76M -1.63B | 14.57M 2.18M 1.94M 1.81M 1.64M 3.1M 211M 3.12M 21.75M 8.52M 107M 8.17M 7.99M 344M |
| Net Debt | -1.57B -235M -210M -195M -177M -335M -22.71B -336M -2.35B -919M -11.58B -881M -862M -37.15B | -1.54B -230M -206M -191M -174M -329M -22.28B -330M -2.3B -902M -11.36B -865M -846M -36.46B |
Employees
489
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-09 | CN¥8.570 | +2.27% | 4,804,156 |
- Stock Market
- Stocks
- 300485 Stock
Select your edition
All financial news and data tailored to specific country editions
